Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data

被引：40
作者：
Marrie R.A. [1 ,2 ,10 ]
Walld R. [3 ]
Bolton J.M. [4 ]
Sareen J. [4 ]
Walker J.R. [5 ]
Patten S.B. [6 ]
Singer A. [7 ]
Lix L.M. [2 ]
Hitchon C.A. [1 ]
El-Gabalawy R. [5 ,8 ]
Katz A. [2 ,3 ,7 ]
Fisk J.D. [9 ]
Bernstein C.N. [1 ]
机构：
[1] Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg
[2] Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg
[3] Manitoba Centre for Health Policy, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg
[4] Department of Psychiatry, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg
[5] Department of Clinical Health Psychology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg
[6] Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary
[7] Department of Family Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg
[8] Department of Anesthesia and Perioperative Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg
[9] Departments of Psychiatry, Psychology and Neuroscience, and Medicine, Dalhousie University, Halifax
[10] Health Sciences Center, GF-543, 820 Sherbrook Street, Winnipeg, R3A 1R9, MB
来源：
BMC Research Notes | / 10卷 / 1期
基金：
加拿大健康研究院;
关键词：
Anxiety; Depression; Epidemiology; Multiple sclerosis;
D O I：
10.1186/s13104-017-2958-1
中图分类号：
学科分类号：
摘要：
Objective: Researchers have developed case definitions to estimate incidence and lifetime prevalence of depression and anxiety disorders in multiple sclerosis (MS) using administrative data. For policymakers however, the prevalence of a disease requiring ongoing treatment during a given period such as annual period prevalence may be more relevant for decision-making. We tested a case definition for annual period prevalence of depression and anxiety disorders in MS using administrative data. Results: Using population-based administrative (health claims) data from Manitoba, Canada we identified 1922 persons with incident MS from 1989 to 2012, and 11,392 age, sex and geographically-matched controls from the general population. As compared to controls, MS patients had an elevated annual prevalence ratio of depression (1.77; 95% confidence interval [CI] 1.64, 1.91), and anxiety disorders (1.46; 95% CI 1.35, 1.58). The annual prevalence of depression in our matched cohort was similar to that observed in the 2012 Canadian Community Health Survey, although the annual prevalence of anxiety was slightly higher. Administrative data can be used to estimate the annual period prevalence of psychiatric disorders in MS. © 2017 The Author(s).
引用
收藏
相关论文
共 18 条
  • [1] Marrie R., Reider N., Cohen J., Stuve O., Trojano M., Sorensen P.S., Cutter G., The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review, Mult Scler J, 21, 3, pp. 305-317, (2015)
  • [2] Marrie R.A., Elliott L., Marriott J., Cossoy M., Blanchard J., Leung S., Yu N., Effect of comorbidity on mortality in multiple sclerosis, Neurology, 85, 3, pp. 240-247, (2015)
  • [3] Marrie R.A., Elliott L., Marriott J., Cossoy M., Tennakoon A., Yu N., Comorbidity increases the risk of hospitalizations in multiple sclerosis, Neurology, 84, 4, pp. 350-358, (2015)
  • [4] Marrie R.A., Fisk J.D., Yu B.N., Leung S., Elliott L., Caetano P., Warren S., Evans C., Wolfson C., Svenson L.W., Et al., Mental comorbidity and multiple sclerosis: Validating administrative data to support population-based surveillance, BMC Neurol, 13, 1, (2013)
  • [5] Baxter A.J., Vos T., Scott K.M., Norman R.E., Flaxman A.D., Blore J., Whiteford H.A., The regional distribution of anxiety disorders: Implications for the Global Burden of Disease Study, 2010, Int J Methods Psychiatr Res, 23, 4, pp. 422-438, (2014)
  • [6] Ferrari A.J., Charlson F.J., Norman R.E., Patten S.B., Freedman G., Murray C.J.L., Vos T., Whiteford H.A., Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study 2010, PLoS Med, 10, 11, (2013)
  • [7] Mental Health Action Plan 2013-2020, (2013)
  • [8] Keller M.B., Boland R.J., Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression, Biol Psychiatr, 44, 5, pp. 348-360, (1998)
  • [9] Bockting C.L., Hollon S.D., Jarrett R.B., Kuyken W., Dobson K., A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrence, Clin Psychol Rev, 41, pp. 16-26, (2015)
  • [10] Marrie R.A., Walld R., Bolton J.M., Sareen J., Walker J.R., Patten S.B., Singer A., Lix L.M., Hitchon C.A., El-Gabalawy H., Et al., Increased incidence of psychiatric disorders in immune-mediated inflammatory disease, J Psychosom Res, 101, pp. 17-23, (2017)
12